CD18-dependent activation of the neutrophil NADPH oxidase during phagocytosis of Escherichia coli or Staphylococcus aureus is regulated by class III but not class I or II PI3Ks

Blood

Volumn 112, Issue 13, 2008, Pages 5202-5211

  Anderson, Karen E ^a   Boyle, Keith B ^a   Davidson, Keith ^a   Chessa, Tamara A M ^a   Kulkarni, Suhasini ^a   Jarvis, Gavin E ^b   Sindrilaru, Anca ^c   Scharffetter Kochanek, Karin ^c   Rausch, Oliver ^d   Stephens, Len R ^a   Hawkins, Phillip T ^a  

^a BABRAHAM INSTITUTE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY HOSPITAL ULM   (Germany)

^d UCB PHARMA   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BETA2 INTEGRIN; CD18 ANTIGEN; PHOSPHATIDYLINOSITOL 3 KINASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; NEUTROPHIL CYTOSOL FACTOR 40K; PHOSPHOPROTEIN; POLYPHOSPHOINOSITIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BACTERIAL CELL; BONE MARROW CULTURE; CELL CULTURE; ESCHERICHIA COLI; HUMAN; HUMAN CELL; KNOCKOUT MOUSE; MACROPHAGE; MOUSE; NONHUMAN; PHAGOCYTOSIS; PHAGOSOME; PRIORITY JOURNAL; RNA INTERFERENCE; STAPHYLOCOCCUS AUREUS; WESTERN BLOTTING; ANIMAL; CELL LINE; ENZYME ACTIVATION; ENZYMOLOGY; IMMUNOLOGY; METABOLISM; NEUTROPHIL; PHYSIOLOGY;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; ANTIGENS, CD18; CELL LINE; ENZYME ACTIVATION; ESCHERICHIA COLI; HUMANS; MICE; NADPH OXIDASE; NEUTROPHILS; PHAGOCYTOSIS; PHOSPHATIDYLINOSITOL PHOSPHATES; PHOSPHOPROTEINS; STAPHYLOCOCCUS AUREUS;

EID: 58149402411     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-04-149450     Document Type: Article

References (57)

1. Segal AW. How neutrophils kill microbes. Ann Rev Immunol. 2005;23:197-223.
2. Underhill DM, Ozinsky A. Phagocytosis of microbes: complexity in action. Ann Rev Immunol. 2002;20:825-852.
3. Scharffetter-Kochanek K, Lu H, Norman K, et al. Spontaneous skin ulceration and defective T cell function in CD18 null mice. J Exp Med. 1998;188: 119-131.
4. Ross GD, Thompson RA, Walport MJ, et al. Characterization of patients with an increased susceptibility to bacterial infections and a genetic deficiency of leukocyte membrane complement receptor type 3 and the related membrane antigen LFA-1. Blood. 1985;66:882-890.
5. Anderson DC, Springer TA. Leukocyte adhesion deficiency: an inherited defect in the Mac-1. LFA-1 and p150,95 glycoproteins. Ann Rev Med. 1987;38:175-194.
6. Cross AR, Segal AW. The NADPH oxidase of professional phagocytes-prototype of the NOX electron transport chain systems. Biochim Biophys Acta. 2004;1657:1-22.
7. Heyworth PG, Cross AR, Curnutte JT. Chronic granulomatous disease. Curr Opin Immunol. 2003;15:578-584.
8. Winkelstein JA, Marino MC, Johnston RB Jr, et al. Chronic granulomatous disease: report on a national registry of 368 patients. Medicine. 2000;79: 155-169.
9. Zhou MJ, Brown EJ. CR3 (Mac-1, alpha M beta 2, CD11b/CD18) and Fc gamma RIII cooperate in generation of a neutrophil respiratory burst: requirement for Fc gamma RIII and tyrosine phos-phorylation. J Cell Biol. 1994;125:1407-1416.
10. van Bruggen R, Zweers D, van Diepen A, et al. Complement receptor 3 and Toll-like receptor 4 act sequentially in uptake and intracellular killing of unopsonized Salmonella enterica serovar Typhimurium by human neutrophils. Infect Immun. 2007;75:2655-2660.
11. Perisic O, Wilson MI, Karathanassis D, et al. The role of phosphoinositides and phosphorylation in regulation of NADPH oxidase. Adv Enzyme Regul. 2004;44:279-298.
12. Hawkins PT, Davidson K, Stephens LR. The role of PI3Ks in the regulation of the neutrophil NADPH oxidase. Biochem Soc Symp. 2007;74: 59-67.
13. Vanhaesebroeck B, Leevers SJ, Ahmadi K, et al. Synthesis and function of 3-phosphorylated inositol lipids. Ann Rev Biochem. 2001;70:535-602.
14. Hawkins PT, Anderson KE, Davidson K, Stephens LR. Signalling through class I PI3Ks in mammalian cells. Biochem Soc Trans. 2006;34: 647-662.
15. Lemmon MA. Pleckstrin homology (PH) domains and phosphoinositides. Biochem Soc Symp. 2007;74:81-93.
16. Condliffe AM, Davison K, Anderson KE, etal. Sequential activation of class IB and class IA PI3K is important for the primed respiratory burst of human but not murine neutrophils. Blood. 2005;106: 1432-1440.
17. Boulven I, Levasseur S, Marois S, Pare G, Rollet-Labelle E, Naccache PH. Class IAphosphatidyl-inositide 3-kinases, rather than p110 gamma, regulate formyl-methionyl-leucyl-phenylalanine-stimulated chemotaxis and superoxide production in differentiated neutrophil-like PLB-985 cells. J Immunol. 2006;176:7621-7627.
18. Puri KD, Doggett TA, Huang CY, et al. The role of endothelial PI3Kgamma activity in neutrophil trafficking. Blood. 2005;106:150-157.
19. Leverrier Y, Okkenhaug K, Sawyer C, Bilancio A, Vanhaesebroeck B, Ridley AJ. Class I phospho-inositide 3-kinase p110beta is required for apoptotic cell and Fcgamma receptor-mediated phagocytosis by macrophages. J Biol Chem. 2003;278:38437-38442.
20. Vieira OV, Botelho RJ, Rameh L, et al. Distinct roles of class I and class III phosphatidylinositol 3-kinases in phagosome formation and maturation. J Cell Biol. 2001;155:19-25.
21. Marshall JG, Booth JW, Stambolic V, et al. Restricted accumulation of phosphatidylinositol 3-kinase products in a plasmalemmal subdomain during Fcγ receptor-mediated phagocytosis. J Cell Biol. 2001;153:1369-1380.
22. Backer JM. The regulation and function of class III PI3Ks; novel roles for Vps34. Biochem J. 2008; 410:1-17.
23. Misra S, Miller M, Hurley JH. Recognizing phosphatidylinositol 3-phosphate. Cell. 2001;107:559-562.
24. Ellson CD, Anderson KE, Morgan G, et al. Phosphatidylinositol 3-phosphate is generated in phagosomal membranes. Curr Biol. 2001;11:1631-1635.
25. Shin HW, Hayashi M, Christoforidis S, et al. An enzymatic cascade of Rab5 effectors regulates phosphoinositide turnover in the endocytic pathway. J Cell Biol. 2005;170:607-618.
26. Falasca M, Maffucci T Role of class II phosphoinositide 3-kinase in cell signalling. Biochem Soc Transact. 2007;35:211-214.
27. Ellson C, Davidson K, Anderson K, Stephens LR, Hawkns PT. PtdIns3P binding to the PX domain of p40phox is a physiological signal in NADPH oxidase activation. EMBO J. 2006;25:4468-4478.
28. Fratti RA, Backer JM, Gruenberg J, Corvera S, Deretic V. Role of phosphatidylinositol 3-kinase and Rab5 effectors in phagosomal biogenesis and mycobacterial phagosome maturation arrest. J Cell Biol. 2001;154:631-644.
29. Deretic V, Singh S, Master S, et al. Mycobacteruim tuberculosis inhibition of phagolysosome biogenesis and autophagy as a host defence mechanism. Cell Microbiol. 2006;8:719-727.
30. Suh C-I, Stull ND, Li XJ, et al. The phosphoinositide-binding protein p40phox activates the NADPH oxidase during FcγIIA receptor-induced phagocytosis. J Exp Med. 2006; 203:1915-1925.
31. Ellson CD, Davidson K, Ferguson GJ, O'Connor R, Stephens LR, Hawkins PT. Neutrophils from p40phox-/- mice exhibit severe defects in NADPH oxidase regulation and oxidant-dependent bacterial killing. J Exp Med. 2006;203: 1927-1937.
32. Okkenhaug K, Bilancio A, Farjot G, et al. Impaired B and T cell antigen receptor signaling in p110delta PI 3-kinase mutant mice. Science. 2002;297:1031-1034.
33. Harada K, Truong AB, Cai T, Khavari PA. The class II phosphoinositide 3-kinase C2beta is not essential for epidermal differentiation. Mol Cell Biol. 2005;25:11122-11130.
34. Park SY, Ueda S, Ohno H, et al. Resistance of Fc receptor-deficient mice to fatal glomerulonephritis. J Clin Ivest. 1998;102:1229-1238.
35. Hirsch E, Katanaev VL, Garlanda C, et al. Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation. Science. 2000; 287:1049-1053.
36. Pollock JD, Williams DA, Gifford MAC, et al. Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production. Nat Gen. 1995;9:202-209.
37. Colucci F, Soudais C, Rosmaraki E, Vanes L, Tybulewicz VL, Di Santo JP. Dissecting NKcell development using a novel alymphoid mouse model: investigating the role of the c-abl proto-oncogene in murine NK cell differentiation. J Immunol. 1999;162:2761-2765.
38. Choi HS, Kim JW, Cha YN, Kim C. Aquantitative nitroblue tetrazolium assay for determining intracellular superoxide anion production in phagocytic cells. J Immunoassay Immunochem. 2006; 27:31-44.
39. Cox D, Tseng C-C, Bjekic G, Greenberg S. A requirement for phosphatidylinositol 3-kinase in pseudopod extension. J Biol Chem. 1999;274: 1240-1247.
40. Knight ZA, Gonzalez B, Feldman ME, et al. A pharmacological map of the PI3-K family defines a role for p110alpha in insulin signalling. Cell. 2006;125:733-747.
41. Jackson SP, Schoenwaelder SM, Goncalves I, et al. PI 3-kinase p110beta: a new target for antithrombotic therapy. Nat Med. 2005;11:507-514.
42. Sadhu C, Dick K, Tino WT, Staunton DE. Selective role of PI3K delta in neutrophil inflammatory responses. Biochem Biophys Res Commun. 2003;308:764-769.
43. Traer CJ, Foster FM, Abraham SM, Fry MJ. Are class II phosphoinositide 3-kinases potential targets for anticancer therapies? Bull Cancer. 2006; 93:E53-E58.
44. Chen J, He R, Minshall RD, et al. Characterization of a mutation in the phox homology domain of the NADPH oxidase component p40phox identifies a mechanism for negative regulation of su-peroxide production. J Biol Chem. 2007;282: 30273-30284.
45. Honbou K, Minakami R, Yuzawa S, et al. Full-length p40phox structure suggests a basis for regulation mechanism of its membrane binding. EMBO J. 2007;26:1176-1186.
46. Bissonnette SA, Glazier CM, Stewart MQ, Brown GE, Ellson CD, Yaffe MB. Phosphatidylinositolo 3-phosphate-dependent and -independent functions of p40phox in activation of the neutrophil NADPH oxidase. J Biol Chem. 2008;283:2108-2119.
47. Lee JS, Nauseef WM, Moeenrezakhanlou A, et al. Monocyte p110alpha phosphatidylinositol 3-kinase regulates phagocytosis, the phagocyte oxidase, and cytokinase production. J Leukoc Biol. 2007;81:1548-1561.
48. Allen LA, Aderem A. Molecular definition of distinct cytoskeletal structures involved in complement- and Fc receptor-mediated phagocytosis in macrophages. J Exp Med. 1996;184:627-637.
49. Sasaki T, Irie-Sasaki J, Jones RG, et al. Function of PI3Kgamma in thymocyte development, T cell activation, and neutrophil migration. Science. 2000;287:1040-1046.
50. Li Z, Jiang H, Xie W, Zhang Z, Smrcka AV, Wu D. Roles of PLC-beta2 and -beta3 and PI3Kgamma in chemoattractant-mediated signal transduction. Science. 2000;287:1046-1049.
51. Gao XP, Zhu X, Fu J, Liu Q, Frey RS, Malik AB. Blockade of class IA phosphoinositide 3-kinase in neutrophils prevents NADPH oxidase activation-and adhesion-dependent inflammation. J Biol Chem. 2007;282:6116-6125.
52. Mocsai A, Abram CL, Jakus Z, Hu Y, Lanier LL, Lowell CA. Integrin signalling in neutrophils and macrophages uses adaptors containing immuno-receptor tyrosine-based activation motifs. Nat Immunol. 2006;7:1326-1333.
53. Maira SM, Voliva C, Garcia-Echeverria C. Class IA phosphatidylinositol 3-kinase: from their biologic implication in human cancers to drug discovery. Expert Opin Ther Targets. 2008;12:223-238.
54. Ito K, Caramori G, Adcock IM. Therapeutic potential of phosphatdiylinositol 3-kinase inhibitors in inflammatory respiratory disease. J Pharmacol Exp Ther. 2007;321:1-8.
55. Wetzker R, Rommel C. Phosphoinositide 3-kinases as targets for therapeutic intervention. Curr Pharm Des. 2004;10:1915-1922.
56. Vieira OV, Bucci C, Harrison RE, et al. Modulation of Rab5 and Rab7 recruitment to phagosomes by phosphatidylinositol 3-kinase. Mol Cell Biol. 2003; 23:2501-2514.
57. Simonsen A, Wurmser AE, Emr SD, Stenmark H. The role of phosphoinositides in membrane transport. Curr Opin Cell Biol. 2001;13:485-492.